Pricing Log in Create free account

4D Molecular Therapeutics, Inc. (FDMT) vs Inventiva S.A. Sponsored ADR (IVA)

4D Molecular Therapeutics, Inc. and Inventiva S.A. Sponsored ADR are both Biotechnology companies. 4D Molecular Therapeutics, Inc. and Inventiva S.A. Sponsored ADR are of similar size ($740.0M and $711.0M). 4D Molecular Therapeutics, Inc. grew revenue faster over the last twelve months: 278,712.1% against 547.9%. 4D Molecular Therapeutics, Inc. has the higher net margin (−194.7% vs −750.3%) and the lower return on invested capital (−186.9% vs 0.00%). Across the 18 metrics below, Inventiva S.A. Sponsored ADR leads on 10 and 4D Molecular Therapeutics, Inc. on 8.

Valuation

Metric FDMT IVA Biotechnology median
P/E n/m n/m 8.50
P/S 9.27 5.79 9.71
P/B 2.09 1.66 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.01 0.64
EV/Sales 5.56 (0.10) 9.21
Earnings yield (21.66%) (121.19%) (33.15%)
Free cash flow yield (18.28%) (120.95%) (25.50%)

Profitability

Metric FDMT IVA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (214.24%) 0.00% 0.00%
Net margin (194.74%) (750.28%) 0.00%
Free cash flow margin (169.51%) 0.00% 0.00%
Return on equity (43.25%) 0.00% (56.36%)
Return on assets (37.09%) 0.00% (48.04%)
Return on invested capital (186.91%) 0.00% 0.00%

Growth

Metric FDMT IVA Biotechnology median
Revenue growth (TTM) 278,712.12% 547.89% 6.02%
EPS growth (last fiscal year) 18.79% 35.44% 30.26%
Revenue growth, 5-year CAGR 44.32% 8.33% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FDMT IVA Biotechnology median
Debt to equity 0.05 1.13 0.00
Current ratio 8.03 3.81 4.72
Net debt to EBITDA 2.52 0.29 0.96

Dividend

Metric FDMT IVA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FDMT IVA Biotechnology median
Market cap 710.99m 739.99m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack